Lv1
35 积分 2021-02-22 加入
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
15小时前
已完结
The immunology of vitiligo
3天前
已完结
The evolving landscape of obesity pharmacotherapy
4天前
已完结
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?
9天前
已完结
Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
26天前
已完结
A comprehensive review of small molecules, targets, and pathways in ulcerative colitis treatment
26天前
已完结
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
1个月前
已完结
POS1135 Discovery and Characterization of Novel Oral TNF-Alpha Inhibitors as Potential Treatments for Autoimmune Diseases
1个月前
已关闭
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
2个月前
已完结
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy
2个月前
已完结
皖公网安备34019202002308
